nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—prostate cancer	0.308	1	CbGaD
Darunavir—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.09	0.207	CbGbCtD
Darunavir—CYP3A4—Bicalutamide—prostate cancer	0.0473	0.109	CbGbCtD
Darunavir—CYP3A4—Estramustine—prostate cancer	0.044	0.101	CbGbCtD
Darunavir—CYP3A4—Abiraterone—prostate cancer	0.0392	0.09	CbGbCtD
Darunavir—CYP3A4—Flutamide—prostate cancer	0.0392	0.09	CbGbCtD
Darunavir—CYP3A4—Cabazitaxel—prostate cancer	0.029	0.0666	CbGbCtD
Darunavir—CYP3A4—Estrone—prostate cancer	0.0283	0.0651	CbGbCtD
Darunavir—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0252	0.058	CbGbCtD
Darunavir—CYP3A4—Conjugated Estrogens—prostate cancer	0.0185	0.0426	CbGbCtD
Darunavir—CYP3A4—Mitoxantrone—prostate cancer	0.0168	0.0387	CbGbCtD
Darunavir—CYP3A4—Estradiol—prostate cancer	0.0163	0.0374	CbGbCtD
Darunavir—CYP3A4—Prednisone—prostate cancer	0.014	0.0321	CbGbCtD
Darunavir—CYP3A4—Etoposide—prostate cancer	0.0106	0.0244	CbGbCtD
Darunavir—CYP3A4—Docetaxel—prostate cancer	0.00972	0.0223	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—prostate cancer	0.00725	0.0166	CbGbCtD
Darunavir—Fosamprenavir—CYP3A4—prostate cancer	0.00123	0.33	CrCbGaD
Darunavir—Amprenavir—CYP3A5—prostate cancer	0.00118	0.317	CrCbGaD
Darunavir—Amprenavir—CYP2C19—prostate cancer	0.000805	0.216	CrCbGaD
Darunavir—Amprenavir—CYP3A4—prostate cancer	0.000512	0.137	CrCbGaD
Darunavir—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—prostate cancer	0.000251	0.0101	CbGpPWpGaD
Darunavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—prostate cancer	0.000248	0.00995	CbGpPWpGaD
Darunavir—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—prostate cancer	0.00024	0.00963	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—SULT2A1—prostate cancer	0.000232	0.00931	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.000226	0.00908	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP2C19—prostate cancer	0.000215	0.00862	CbGpPWpGaD
Darunavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—prostate cancer	0.000211	0.00846	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP2A6—prostate cancer	0.000207	0.00832	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP2C19—prostate cancer	0.000207	0.00829	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A43—prostate cancer	0.000205	0.00823	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP3A43—prostate cancer	0.000202	0.00812	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTCD—prostate cancer	0.0002	0.00803	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTK1—prostate cancer	0.0002	0.00803	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP2A6—prostate cancer	0.000199	0.008	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—CYP7B1—prostate cancer	0.000197	0.00791	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.000195	0.00781	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.000192	0.00772	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—NQO1—prostate cancer	0.00019	0.00761	CbGpPWpGaD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.000183	0.00735	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—CYP1B1—prostate cancer	0.000182	0.0073	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP2E1—prostate cancer	0.000176	0.00707	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP2E1—prostate cancer	0.00017	0.0068	CbGpPWpGaD
Darunavir—CYP3A4—Aflatoxin activation and detoxification—GGT1—prostate cancer	0.000169	0.00677	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A43—prostate cancer	0.000166	0.00667	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.000166	0.00664	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP1B1—prostate cancer	0.000161	0.00645	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7B1—prostate cancer	0.000159	0.0064	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—COMT—prostate cancer	0.000159	0.00638	CbGpPWpGaD
Darunavir—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—prostate cancer	0.000158	0.00634	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP7B1—prostate cancer	0.000157	0.00631	CbGpPWpGaD
Darunavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.000156	0.00628	CbGpPWpGaD
Darunavir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—prostate cancer	0.000151	0.00608	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.000148	0.00592	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—GSTM1—prostate cancer	0.000145	0.00583	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.000142	0.00571	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—CYP1A1—prostate cancer	0.000138	0.00553	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—prostate cancer	0.000137	0.00549	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	0.000135	0.00542	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—CYP2C18—prostate cancer	0.000133	0.00535	CbGpPWpGaD
Darunavir—CYP3A4—Irinotecan Pathway—APC—prostate cancer	0.000132	0.0053	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	0.00013	0.00521	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP7B1—prostate cancer	0.000129	0.00519	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP1A1—prostate cancer	0.000127	0.00508	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP1A1—prostate cancer	0.000122	0.00489	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—prostate cancer	0.000121	0.00485	CbGpPWpGaD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	0.000115	0.00463	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	0.000111	0.00445	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.00011	0.00439	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.000108	0.00432	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.000106	0.00427	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000104	0.00418	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	9.91e-05	0.00397	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	9.91e-05	0.00397	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	9.8e-05	0.00393	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	9.77e-05	0.00392	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	9.32e-05	0.00374	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTM3—prostate cancer	9.32e-05	0.00374	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	9.19e-05	0.00369	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	9.19e-05	0.00369	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	9.06e-05	0.00363	CbGpPWpGaD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	8.99e-05	0.00361	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	8.93e-05	0.00358	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	8.83e-05	0.00354	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—NAT1—prostate cancer	8.83e-05	0.00354	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	8.81e-05	0.00353	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	8.73e-05	0.0035	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	8.71e-05	0.00349	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	8.61e-05	0.00346	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	8.59e-05	0.00344	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	8.5e-05	0.00341	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	8.25e-05	0.00331	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	8.14e-05	0.00327	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	8.07e-05	0.00324	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	7.86e-05	0.00315	CbGpPWpGaD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	7.58e-05	0.00304	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	7.41e-05	0.00297	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	7.32e-05	0.00294	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	7.24e-05	0.0029	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	7.23e-05	0.0029	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	6.98e-05	0.0028	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	6.94e-05	0.00278	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	6.87e-05	0.00276	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	6.85e-05	0.00275	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	6.77e-05	0.00272	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	6.69e-05	0.00268	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	6.69e-05	0.00268	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	6.62e-05	0.00266	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	6.6e-05	0.00265	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	6.53e-05	0.00262	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	6.51e-05	0.00261	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	6.44e-05	0.00258	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	6.37e-05	0.00256	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	6.3e-05	0.00253	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	5.94e-05	0.00238	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	5.89e-05	0.00236	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	5.81e-05	0.00233	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA3—prostate cancer	5.69e-05	0.00228	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	5.63e-05	0.00226	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	5.61e-05	0.00225	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	5.37e-05	0.00215	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	5.29e-05	0.00212	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	5.26e-05	0.00211	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA4—prostate cancer	5.2e-05	0.00209	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	5.2e-05	0.00209	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	5.19e-05	0.00208	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	5.13e-05	0.00206	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	5.11e-05	0.00205	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA2—prostate cancer	5.07e-05	0.00203	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	5.01e-05	0.00201	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	4.94e-05	0.00198	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA1—prostate cancer	4.89e-05	0.00196	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTO1—prostate cancer	4.84e-05	0.00194	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—NAT2—prostate cancer	4.84e-05	0.00194	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	4.77e-05	0.00191	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	4.77e-05	0.00191	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	4.64e-05	0.00186	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	4.58e-05	0.00184	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	4.31e-05	0.00173	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	4.26e-05	0.00171	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	4.25e-05	0.00171	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	4.06e-05	0.00163	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	4.01e-05	0.00161	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—HPGDS—prostate cancer	3.87e-05	0.00155	CbGpPWpGaD
Darunavir—Epistaxis—Doxorubicin—prostate cancer	3.87e-05	0.000169	CcSEcCtD
Darunavir—Anorexia—Capecitabine—prostate cancer	3.87e-05	0.000169	CcSEcCtD
Darunavir—Nausea—Estradiol—prostate cancer	3.86e-05	0.000169	CcSEcCtD
Darunavir—Vomiting—Mitoxantrone—prostate cancer	3.85e-05	0.000169	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	3.84e-05	0.00154	CbGpPWpGaD
Darunavir—Convulsion—Prednisone—prostate cancer	3.84e-05	0.000168	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—prostate cancer	3.83e-05	0.000168	CcSEcCtD
Darunavir—Hypertension—Prednisone—prostate cancer	3.82e-05	0.000167	CcSEcCtD
Darunavir—Rash—Mitoxantrone—prostate cancer	3.82e-05	0.000167	CcSEcCtD
Darunavir—Dermatitis—Mitoxantrone—prostate cancer	3.82e-05	0.000167	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.82e-05	0.000167	CcSEcCtD
Darunavir—Headache—Mitoxantrone—prostate cancer	3.8e-05	0.000166	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	3.79e-05	0.00152	CbGpPWpGaD
Darunavir—Insomnia—Docetaxel—prostate cancer	3.79e-05	0.000166	CcSEcCtD
Darunavir—Myalgia—Prednisone—prostate cancer	3.77e-05	0.000165	CcSEcCtD
Darunavir—Arthralgia—Prednisone—prostate cancer	3.77e-05	0.000165	CcSEcCtD
Darunavir—Paraesthesia—Docetaxel—prostate cancer	3.76e-05	0.000165	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—prostate cancer	3.76e-05	0.000165	CcSEcCtD
Darunavir—Anxiety—Prednisone—prostate cancer	3.76e-05	0.000165	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—GSTT1—prostate cancer	3.75e-05	0.00151	CbGpPWpGaD
Darunavir—Bradycardia—Doxorubicin—prostate cancer	3.75e-05	0.000164	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.74e-05	0.000164	CcSEcCtD
Darunavir—Dyspnoea—Docetaxel—prostate cancer	3.73e-05	0.000164	CcSEcCtD
Darunavir—Somnolence—Docetaxel—prostate cancer	3.72e-05	0.000163	CcSEcCtD
Darunavir—Discomfort—Prednisone—prostate cancer	3.72e-05	0.000163	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—prostate cancer	3.72e-05	0.000163	CcSEcCtD
Darunavir—Hypersensitivity—Etoposide—prostate cancer	3.71e-05	0.000163	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	3.71e-05	0.00149	CbGpPWpGaD
Darunavir—Haemoglobin—Doxorubicin—prostate cancer	3.7e-05	0.000162	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.7e-05	0.000162	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—prostate cancer	3.69e-05	0.000162	CcSEcCtD
Darunavir—Flushing—Epirubicin—prostate cancer	3.69e-05	0.000162	CcSEcCtD
Darunavir—Dyspepsia—Docetaxel—prostate cancer	3.69e-05	0.000162	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—prostate cancer	3.68e-05	0.000161	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—prostate cancer	3.68e-05	0.000161	CcSEcCtD
Darunavir—Insomnia—Capecitabine—prostate cancer	3.67e-05	0.000161	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—prostate cancer	3.66e-05	0.00016	CcSEcCtD
Darunavir—Paraesthesia—Capecitabine—prostate cancer	3.64e-05	0.00016	CcSEcCtD
Darunavir—Decreased appetite—Docetaxel—prostate cancer	3.64e-05	0.00016	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—prostate cancer	3.63e-05	0.000159	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—prostate cancer	3.63e-05	0.000159	CcSEcCtD
Darunavir—Gastrointestinal disorder—Docetaxel—prostate cancer	3.62e-05	0.000158	CcSEcCtD
Darunavir—Asthenia—Etoposide—prostate cancer	3.62e-05	0.000158	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—prostate cancer	3.62e-05	0.000158	CcSEcCtD
Darunavir—Dyspnoea—Capecitabine—prostate cancer	3.62e-05	0.000158	CcSEcCtD
Darunavir—Fatigue—Docetaxel—prostate cancer	3.61e-05	0.000158	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—prostate cancer	3.61e-05	0.000158	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—prostate cancer	3.61e-05	0.000158	CcSEcCtD
Darunavir—Nausea—Mitoxantrone—prostate cancer	3.6e-05	0.000158	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—prostate cancer	3.59e-05	0.000157	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—prostate cancer	3.58e-05	0.000157	CcSEcCtD
Darunavir—Pain—Docetaxel—prostate cancer	3.58e-05	0.000157	CcSEcCtD
Darunavir—Constipation—Docetaxel—prostate cancer	3.58e-05	0.000157	CcSEcCtD
Darunavir—Dyspepsia—Capecitabine—prostate cancer	3.57e-05	0.000156	CcSEcCtD
Darunavir—Chills—Epirubicin—prostate cancer	3.57e-05	0.000156	CcSEcCtD
Darunavir—Pruritus—Etoposide—prostate cancer	3.57e-05	0.000156	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	3.56e-05	0.00143	CbGpPWpGaD
Darunavir—Shock—Prednisone—prostate cancer	3.55e-05	0.000156	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	3.55e-05	0.00142	CbGpPWpGaD
Darunavir—Visual impairment—Doxorubicin—prostate cancer	3.55e-05	0.000155	CcSEcCtD
Darunavir—Nervous system disorder—Prednisone—prostate cancer	3.54e-05	0.000155	CcSEcCtD
Darunavir—Tachycardia—Prednisone—prostate cancer	3.53e-05	0.000155	CcSEcCtD
Darunavir—Decreased appetite—Capecitabine—prostate cancer	3.53e-05	0.000155	CcSEcCtD
Darunavir—Alopecia—Epirubicin—prostate cancer	3.51e-05	0.000154	CcSEcCtD
Darunavir—Skin disorder—Prednisone—prostate cancer	3.51e-05	0.000154	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	3.5e-05	0.00141	CbGpPWpGaD
Darunavir—Gastrointestinal disorder—Capecitabine—prostate cancer	3.5e-05	0.000153	CcSEcCtD
Darunavir—Fatigue—Capecitabine—prostate cancer	3.5e-05	0.000153	CcSEcCtD
Darunavir—Hyperhidrosis—Prednisone—prostate cancer	3.49e-05	0.000153	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—prostate cancer	3.48e-05	0.000153	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—prostate cancer	3.48e-05	0.000152	CcSEcCtD
Darunavir—Constipation—Capecitabine—prostate cancer	3.47e-05	0.000152	CcSEcCtD
Darunavir—Pain—Capecitabine—prostate cancer	3.47e-05	0.000152	CcSEcCtD
Darunavir—Erythema—Epirubicin—prostate cancer	3.46e-05	0.000152	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—prostate cancer	3.46e-05	0.000152	CcSEcCtD
Darunavir—Feeling abnormal—Docetaxel—prostate cancer	3.45e-05	0.000151	CcSEcCtD
Darunavir—Diarrhoea—Etoposide—prostate cancer	3.45e-05	0.000151	CcSEcCtD
Darunavir—Anorexia—Prednisone—prostate cancer	3.44e-05	0.000151	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—prostate cancer	3.44e-05	0.000151	CcSEcCtD
Darunavir—Gastrointestinal pain—Docetaxel—prostate cancer	3.43e-05	0.00015	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—prostate cancer	3.42e-05	0.00015	CcSEcCtD
Darunavir—Flushing—Doxorubicin—prostate cancer	3.42e-05	0.00015	CcSEcCtD
Darunavir—Flatulence—Epirubicin—prostate cancer	3.41e-05	0.00015	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—prostate cancer	3.39e-05	0.000149	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—NCOA2—prostate cancer	3.38e-05	0.00136	CbGpPWpGaD
Darunavir—Feeling abnormal—Capecitabine—prostate cancer	3.34e-05	0.000146	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—prostate cancer	3.34e-05	0.000146	CcSEcCtD
Darunavir—Dizziness—Etoposide—prostate cancer	3.33e-05	0.000146	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—prostate cancer	3.33e-05	0.000146	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—prostate cancer	3.32e-05	0.000146	CcSEcCtD
Darunavir—Gastrointestinal pain—Capecitabine—prostate cancer	3.32e-05	0.000145	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—prostate cancer	3.32e-05	0.000145	CcSEcCtD
Darunavir—Body temperature increased—Docetaxel—prostate cancer	3.31e-05	0.000145	CcSEcCtD
Darunavir—Abdominal pain—Docetaxel—prostate cancer	3.31e-05	0.000145	CcSEcCtD
Darunavir—Chills—Doxorubicin—prostate cancer	3.3e-05	0.000145	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Prednisone—prostate cancer	3.29e-05	0.000144	CcSEcCtD
Darunavir—Insomnia—Prednisone—prostate cancer	3.27e-05	0.000143	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—prostate cancer	3.25e-05	0.000143	CcSEcCtD
Darunavir—Paraesthesia—Prednisone—prostate cancer	3.24e-05	0.000142	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—prostate cancer	3.22e-05	0.000141	CcSEcCtD
Darunavir—Urticaria—Capecitabine—prostate cancer	3.22e-05	0.000141	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—prostate cancer	3.21e-05	0.000141	CcSEcCtD
Darunavir—Body temperature increased—Capecitabine—prostate cancer	3.21e-05	0.000141	CcSEcCtD
Darunavir—Abdominal pain—Capecitabine—prostate cancer	3.21e-05	0.000141	CcSEcCtD
Darunavir—Vomiting—Etoposide—prostate cancer	3.2e-05	0.00014	CcSEcCtD
Darunavir—Erythema—Doxorubicin—prostate cancer	3.2e-05	0.00014	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—prostate cancer	3.2e-05	0.00014	CcSEcCtD
Darunavir—Anaemia—Epirubicin—prostate cancer	3.2e-05	0.00014	CcSEcCtD
Darunavir—Agitation—Epirubicin—prostate cancer	3.18e-05	0.000139	CcSEcCtD
Darunavir—Dyspepsia—Prednisone—prostate cancer	3.18e-05	0.000139	CcSEcCtD
Darunavir—Rash—Etoposide—prostate cancer	3.18e-05	0.000139	CcSEcCtD
Darunavir—Dermatitis—Etoposide—prostate cancer	3.18e-05	0.000139	CcSEcCtD
Darunavir—Headache—Etoposide—prostate cancer	3.16e-05	0.000138	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—prostate cancer	3.16e-05	0.000138	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.15e-05	0.00127	CbGpPWpGaD
Darunavir—Decreased appetite—Prednisone—prostate cancer	3.14e-05	0.000138	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—prostate cancer	3.14e-05	0.000137	CcSEcCtD
Darunavir—Malaise—Epirubicin—prostate cancer	3.12e-05	0.000137	CcSEcCtD
Darunavir—Fatigue—Prednisone—prostate cancer	3.11e-05	0.000136	CcSEcCtD
Darunavir—Vertigo—Epirubicin—prostate cancer	3.11e-05	0.000136	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.11e-05	0.00125	CbGpPWpGaD
Darunavir—Syncope—Epirubicin—prostate cancer	3.1e-05	0.000136	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—prostate cancer	3.1e-05	0.000136	CcSEcCtD
Darunavir—Constipation—Prednisone—prostate cancer	3.09e-05	0.000135	CcSEcCtD
Darunavir—Hypersensitivity—Docetaxel—prostate cancer	3.09e-05	0.000135	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—prostate cancer	3.08e-05	0.000135	CcSEcCtD
Darunavir—Palpitations—Epirubicin—prostate cancer	3.06e-05	0.000134	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—prostate cancer	3.04e-05	0.000133	CcSEcCtD
Darunavir—Cough—Epirubicin—prostate cancer	3.02e-05	0.000132	CcSEcCtD
Darunavir—Asthenia—Docetaxel—prostate cancer	3.01e-05	0.000132	CcSEcCtD
Darunavir—Convulsion—Epirubicin—prostate cancer	3e-05	0.000131	CcSEcCtD
Darunavir—Nausea—Etoposide—prostate cancer	2.99e-05	0.000131	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	2.99e-05	0.0012	CbGpPWpGaD
Darunavir—Hypertension—Epirubicin—prostate cancer	2.99e-05	0.000131	CcSEcCtD
Darunavir—Hypersensitivity—Capecitabine—prostate cancer	2.99e-05	0.000131	CcSEcCtD
Darunavir—Feeling abnormal—Prednisone—prostate cancer	2.98e-05	0.00013	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—prostate cancer	2.97e-05	0.00013	CcSEcCtD
Darunavir—Pruritus—Docetaxel—prostate cancer	2.96e-05	0.00013	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—prostate cancer	2.96e-05	0.00013	CcSEcCtD
Darunavir—Gastrointestinal pain—Prednisone—prostate cancer	2.95e-05	0.000129	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	2.95e-05	0.00118	CbGpPWpGaD
Darunavir—Arthralgia—Epirubicin—prostate cancer	2.95e-05	0.000129	CcSEcCtD
Darunavir—Chest pain—Epirubicin—prostate cancer	2.95e-05	0.000129	CcSEcCtD
Darunavir—Myalgia—Epirubicin—prostate cancer	2.95e-05	0.000129	CcSEcCtD
Darunavir—Agitation—Doxorubicin—prostate cancer	2.94e-05	0.000129	CcSEcCtD
Darunavir—Anxiety—Epirubicin—prostate cancer	2.94e-05	0.000129	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.93e-05	0.000128	CcSEcCtD
Darunavir—Discomfort—Epirubicin—prostate cancer	2.91e-05	0.000128	CcSEcCtD
Darunavir—Asthenia—Capecitabine—prostate cancer	2.91e-05	0.000128	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—GGT1—prostate cancer	2.9e-05	0.00116	CbGpPWpGaD
Darunavir—Malaise—Doxorubicin—prostate cancer	2.89e-05	0.000127	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—prostate cancer	2.88e-05	0.000126	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—prostate cancer	2.88e-05	0.000126	CcSEcCtD
Darunavir—Syncope—Doxorubicin—prostate cancer	2.87e-05	0.000126	CcSEcCtD
Darunavir—Urticaria—Prednisone—prostate cancer	2.87e-05	0.000126	CcSEcCtD
Darunavir—Pruritus—Capecitabine—prostate cancer	2.87e-05	0.000126	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—prostate cancer	2.87e-05	0.000126	CcSEcCtD
Darunavir—Diarrhoea—Docetaxel—prostate cancer	2.87e-05	0.000126	CcSEcCtD
Darunavir—Abdominal pain—Prednisone—prostate cancer	2.86e-05	0.000125	CcSEcCtD
Darunavir—Body temperature increased—Prednisone—prostate cancer	2.86e-05	0.000125	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.85e-05	0.00114	CbGpPWpGaD
Darunavir—Confusional state—Epirubicin—prostate cancer	2.85e-05	0.000125	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—prostate cancer	2.83e-05	0.000124	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—prostate cancer	2.82e-05	0.000123	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.81e-05	0.00113	CbGpPWpGaD
Darunavir—Cough—Doxorubicin—prostate cancer	2.8e-05	0.000123	CcSEcCtD
Darunavir—Shock—Epirubicin—prostate cancer	2.78e-05	0.000122	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—prostate cancer	2.78e-05	0.000122	CcSEcCtD
Darunavir—Diarrhoea—Capecitabine—prostate cancer	2.78e-05	0.000122	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.77e-05	0.00111	CbGpPWpGaD
Darunavir—Nervous system disorder—Epirubicin—prostate cancer	2.77e-05	0.000121	CcSEcCtD
Darunavir—Dizziness—Docetaxel—prostate cancer	2.77e-05	0.000121	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—prostate cancer	2.77e-05	0.000121	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—prostate cancer	2.77e-05	0.000121	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—prostate cancer	2.76e-05	0.000121	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—prostate cancer	2.74e-05	0.00012	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—prostate cancer	2.72e-05	0.000119	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.71e-05	0.00109	CbGpPWpGaD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.71e-05	0.000119	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—prostate cancer	2.69e-05	0.000118	CcSEcCtD
Darunavir—Anorexia—Epirubicin—prostate cancer	2.69e-05	0.000118	CcSEcCtD
Darunavir—Dizziness—Capecitabine—prostate cancer	2.68e-05	0.000118	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—prostate cancer	2.67e-05	0.000117	CcSEcCtD
Darunavir—Vomiting—Docetaxel—prostate cancer	2.66e-05	0.000117	CcSEcCtD
Darunavir—Hypersensitivity—Prednisone—prostate cancer	2.66e-05	0.000117	CcSEcCtD
Darunavir—Rash—Docetaxel—prostate cancer	2.64e-05	0.000116	CcSEcCtD
Darunavir—Dermatitis—Docetaxel—prostate cancer	2.64e-05	0.000116	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—prostate cancer	2.64e-05	0.000116	CcSEcCtD
Darunavir—Headache—Docetaxel—prostate cancer	2.62e-05	0.000115	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—COMT—prostate cancer	2.61e-05	0.00105	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.6e-05	0.00104	CbGpPWpGaD
Darunavir—Asthenia—Prednisone—prostate cancer	2.59e-05	0.000114	CcSEcCtD
Darunavir—Vomiting—Capecitabine—prostate cancer	2.58e-05	0.000113	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.58e-05	0.00103	CbGpPWpGaD
Darunavir—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.57e-05	0.000113	CcSEcCtD
Darunavir—Shock—Doxorubicin—prostate cancer	2.57e-05	0.000113	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.56e-05	0.00103	CbGpPWpGaD
Darunavir—Nervous system disorder—Doxorubicin—prostate cancer	2.56e-05	0.000112	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—prostate cancer	2.56e-05	0.000112	CcSEcCtD
Darunavir—Rash—Capecitabine—prostate cancer	2.56e-05	0.000112	CcSEcCtD
Darunavir—Pruritus—Prednisone—prostate cancer	2.56e-05	0.000112	CcSEcCtD
Darunavir—Insomnia—Epirubicin—prostate cancer	2.56e-05	0.000112	CcSEcCtD
Darunavir—Dermatitis—Capecitabine—prostate cancer	2.55e-05	0.000112	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—prostate cancer	2.55e-05	0.000112	CcSEcCtD
Darunavir—Headache—Capecitabine—prostate cancer	2.54e-05	0.000111	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—prostate cancer	2.54e-05	0.000111	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—prostate cancer	2.54e-05	0.000111	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—prostate cancer	2.53e-05	0.000111	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—prostate cancer	2.52e-05	0.00011	CcSEcCtD
Darunavir—Somnolence—Epirubicin—prostate cancer	2.51e-05	0.00011	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—prostate cancer	2.49e-05	0.000109	CcSEcCtD
Darunavir—Nausea—Docetaxel—prostate cancer	2.49e-05	0.000109	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—prostate cancer	2.49e-05	0.000109	CcSEcCtD
Darunavir—Diarrhoea—Prednisone—prostate cancer	2.47e-05	0.000108	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—prostate cancer	2.46e-05	0.000108	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—prostate cancer	2.44e-05	0.000107	CcSEcCtD
Darunavir—Fatigue—Epirubicin—prostate cancer	2.44e-05	0.000107	CcSEcCtD
Darunavir—Pain—Epirubicin—prostate cancer	2.42e-05	0.000106	CcSEcCtD
Darunavir—Constipation—Epirubicin—prostate cancer	2.42e-05	0.000106	CcSEcCtD
Darunavir—Nausea—Capecitabine—prostate cancer	2.41e-05	0.000106	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.39e-05	0.000959	CbGpPWpGaD
Darunavir—Dizziness—Prednisone—prostate cancer	2.39e-05	0.000105	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.38e-05	0.000104	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—prostate cancer	2.36e-05	0.000104	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.36e-05	0.000946	CbGpPWpGaD
Darunavir—Paraesthesia—Doxorubicin—prostate cancer	2.35e-05	0.000103	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—prostate cancer	2.33e-05	0.000102	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—prostate cancer	2.33e-05	0.000102	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—prostate cancer	2.32e-05	0.000102	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—prostate cancer	2.31e-05	0.000101	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—prostate cancer	2.3e-05	0.000101	CcSEcCtD
Darunavir—Vomiting—Prednisone—prostate cancer	2.3e-05	0.000101	CcSEcCtD
Darunavir—Rash—Prednisone—prostate cancer	2.28e-05	9.98e-05	CcSEcCtD
Darunavir—Dermatitis—Prednisone—prostate cancer	2.28e-05	9.97e-05	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—prostate cancer	2.27e-05	9.96e-05	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.27e-05	0.000909	CbGpPWpGaD
Darunavir—Headache—Prednisone—prostate cancer	2.26e-05	9.92e-05	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.26e-05	9.89e-05	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—prostate cancer	2.25e-05	9.88e-05	CcSEcCtD
Darunavir—Urticaria—Epirubicin—prostate cancer	2.24e-05	9.84e-05	CcSEcCtD
Darunavir—CYP3A4—Metabolism—HAO1—prostate cancer	2.24e-05	0.000897	CbGpPWpGaD
Darunavir—Constipation—Doxorubicin—prostate cancer	2.24e-05	9.8e-05	CcSEcCtD
Darunavir—Pain—Doxorubicin—prostate cancer	2.24e-05	9.8e-05	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.23e-05	0.000896	CbGpPWpGaD
Darunavir—Body temperature increased—Epirubicin—prostate cancer	2.23e-05	9.79e-05	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—prostate cancer	2.23e-05	9.79e-05	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—prostate cancer	2.15e-05	9.44e-05	CcSEcCtD
Darunavir—Nausea—Prednisone—prostate cancer	2.15e-05	9.4e-05	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—prostate cancer	2.14e-05	9.37e-05	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—prostate cancer	2.08e-05	9.12e-05	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—prostate cancer	2.08e-05	9.1e-05	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—prostate cancer	2.07e-05	9.06e-05	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—prostate cancer	2.07e-05	9.06e-05	CcSEcCtD
Darunavir—Asthenia—Epirubicin—prostate cancer	2.03e-05	8.88e-05	CcSEcCtD
Darunavir—Pruritus—Epirubicin—prostate cancer	2e-05	8.76e-05	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—prostate cancer	1.93e-05	8.47e-05	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—prostate cancer	1.93e-05	8.44e-05	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—prostate cancer	1.88e-05	8.22e-05	CcSEcCtD
Darunavir—Dizziness—Epirubicin—prostate cancer	1.87e-05	8.19e-05	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—prostate cancer	1.85e-05	8.11e-05	CcSEcCtD
Darunavir—CYP3A4—Metabolism—PSAT1—prostate cancer	1.82e-05	0.000731	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GRHL1—prostate cancer	1.82e-05	0.000731	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TST—prostate cancer	1.82e-05	0.000731	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ADI1—prostate cancer	1.82e-05	0.000731	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CBR1—prostate cancer	1.82e-05	0.000731	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CSAD—prostate cancer	1.82e-05	0.000731	CbGpPWpGaD
Darunavir—Vomiting—Epirubicin—prostate cancer	1.8e-05	7.87e-05	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—prostate cancer	1.79e-05	7.84e-05	CcSEcCtD
Darunavir—Rash—Epirubicin—prostate cancer	1.78e-05	7.81e-05	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—prostate cancer	1.78e-05	7.8e-05	CcSEcCtD
Darunavir—Headache—Epirubicin—prostate cancer	1.77e-05	7.76e-05	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—prostate cancer	1.73e-05	7.58e-05	CcSEcCtD
Darunavir—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.69e-05	0.00068	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GRHPR—prostate cancer	1.69e-05	0.00068	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.69e-05	0.00068	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CKMT2—prostate cancer	1.69e-05	0.00068	CbGpPWpGaD
Darunavir—Nausea—Epirubicin—prostate cancer	1.68e-05	7.36e-05	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—prostate cancer	1.66e-05	7.28e-05	CcSEcCtD
Darunavir—Rash—Doxorubicin—prostate cancer	1.65e-05	7.22e-05	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—prostate cancer	1.65e-05	7.22e-05	CcSEcCtD
Darunavir—Headache—Doxorubicin—prostate cancer	1.64e-05	7.18e-05	CcSEcCtD
Darunavir—CYP3A4—Metabolism—AOX1—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NAGLU—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—RFK—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTM3—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PGAM2—prostate cancer	1.59e-05	0.000639	CbGpPWpGaD
Darunavir—Nausea—Doxorubicin—prostate cancer	1.55e-05	6.81e-05	CcSEcCtD
Darunavir—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.51e-05	0.000606	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—AMACR—prostate cancer	1.51e-05	0.000606	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.51e-05	0.000606	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NAT1—prostate cancer	1.51e-05	0.000606	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—DEGS1—prostate cancer	1.51e-05	0.000606	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.44e-05	0.000578	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.28e-05	0.000515	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HPGD—prostate cancer	1.28e-05	0.000515	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.21e-05	0.000484	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.17e-05	0.000471	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—MTAP—prostate cancer	1.17e-05	0.000471	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.14e-05	0.000459	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.14e-05	0.000459	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ACSL4—prostate cancer	1.09e-05	0.000438	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.09e-05	0.000438	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ARG2—prostate cancer	1.05e-05	0.00042	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PHGDH—prostate cancer	1.05e-05	0.00042	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—UMPS—prostate cancer	1.05e-05	0.00042	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—LDHB—prostate cancer	1.03e-05	0.000412	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.01e-05	0.000404	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA3—prostate cancer	9.73e-06	0.00039	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—UCP3—prostate cancer	9.73e-06	0.00039	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TCN2—prostate cancer	9.73e-06	0.00039	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PDHA1—prostate cancer	9.73e-06	0.00039	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.28e-06	0.000372	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.28e-06	0.000372	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.9e-06	0.000357	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA4—prostate cancer	8.9e-06	0.000357	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA2—prostate cancer	8.67e-06	0.000348	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ABCG5—prostate cancer	8.57e-06	0.000344	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.57e-06	0.000344	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA1—prostate cancer	8.37e-06	0.000336	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.27e-06	0.000332	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTO1—prostate cancer	8.27e-06	0.000332	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NAT2—prostate cancer	8.27e-06	0.000332	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PLCB2—prostate cancer	7.93e-06	0.000318	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—LRP2—prostate cancer	7.93e-06	0.000318	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.93e-06	0.000318	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—P4HB—prostate cancer	7.78e-06	0.000312	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.57e-06	0.000304	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.38e-06	0.000296	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—MED12—prostate cancer	7.26e-06	0.000291	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GNG5—prostate cancer	7.2e-06	0.000289	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NCOA3—prostate cancer	6.93e-06	0.000278	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HPGDS—prostate cancer	6.62e-06	0.000265	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.57e-06	0.000264	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTT1—prostate cancer	6.42e-06	0.000257	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ACHE—prostate cancer	6.42e-06	0.000257	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.34e-06	0.000254	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.17e-06	0.000248	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PRKACB—prostate cancer	6.14e-06	0.000246	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.07e-06	0.000244	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NCOA2—prostate cancer	5.79e-06	0.000232	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.52e-06	0.000221	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.39e-06	0.000216	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NQO1—prostate cancer	5.33e-06	0.000214	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TH—prostate cancer	5.26e-06	0.000211	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.11e-06	0.000205	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GGT1—prostate cancer	4.95e-06	0.000199	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NCOA1—prostate cancer	4.88e-06	0.000196	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.81e-06	0.000193	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—RXRA—prostate cancer	4.64e-06	0.000186	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—COMT—prostate cancer	4.47e-06	0.000179	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTP1—prostate cancer	4.45e-06	0.000178	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ITPR1—prostate cancer	4.38e-06	0.000176	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TYMS—prostate cancer	4.13e-06	0.000166	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTM1—prostate cancer	4.09e-06	0.000164	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—LPL—prostate cancer	4.01e-06	0.000161	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.87e-06	0.000155	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ERCC2—prostate cancer	3.84e-06	0.000154	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—MTHFR—prostate cancer	3.61e-06	0.000145	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PPARA—prostate cancer	3.54e-06	0.000142	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CAV1—prostate cancer	3.33e-06	0.000134	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.03e-06	0.000122	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—INS—prostate cancer	2.87e-06	0.000115	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CREBBP—prostate cancer	2.81e-06	0.000113	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.67e-06	0.000107	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NOS3—prostate cancer	2.52e-06	0.000101	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.33e-06	9.33e-05	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PTGS2—prostate cancer	2.3e-06	9.24e-05	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PTEN—prostate cancer	2.01e-06	8.06e-05	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—EP300—prostate cancer	1.92e-06	7.69e-05	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.42e-06	5.69e-05	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—AKT1—prostate cancer	1.16e-06	4.65e-05	CbGpPWpGaD
